These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31052420)

  • 1. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
    Gallo S; Vitacolonna A; Bonzano A; Comoglio P; Crepaldi T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T; Komuro I; Yazaki Y
    Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy.
    Mutlak M; Schlesinger-Laufer M; Haas T; Shofti R; Ballan N; Lewis YE; Zuler M; Zohar Y; Caspi LH; Kehat I
    Int J Cardiol; 2018 Nov; 270():204-213. PubMed ID: 29857938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
    Vidal M; Wieland T; Lohse MJ; Lorenz K
    Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
    Bueno OF; De Windt LJ; Tymitz KM; Witt SA; Kimball TR; Klevitsky R; Hewett TE; Jones SP; Lefer DJ; Peng CF; Kitsis RN; Molkentin JD
    EMBO J; 2000 Dec; 19(23):6341-50. PubMed ID: 11101507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload.
    Esposito G; Prasad SV; Rapacciuolo A; Mao L; Koch WJ; Rockman HA
    Circulation; 2001 Mar; 103(10):1453-8. PubMed ID: 11245652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats.
    Chen LM; Kuo WW; Yang JJ; Wang SG; Yeh YL; Tsai FJ; Ho YJ; Chang MH; Huang CY; Lee SD
    Exp Physiol; 2007 Mar; 92(2):409-16. PubMed ID: 17185350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin-mediated modulation of hypertrophic signals in the heart.
    Shibata R; Ouchi N; Ito M; Kihara S; Shiojima I; Pimentel DR; Kumada M; Sato K; Schiekofer S; Ohashi K; Funahashi T; Colucci WS; Walsh K
    Nat Med; 2004 Dec; 10(12):1384-9. PubMed ID: 15558058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis.
    Zhang S; Weinheimer C; Courtois M; Kovacs A; Zhang CE; Cheng AM; Wang Y; Muslin AJ
    J Clin Invest; 2003 Mar; 111(6):833-41. PubMed ID: 12639989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
    Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG
    Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro.
    Ruf S; Piper M; Schlüter KD
    Pflugers Arch; 2002 Jan; 443(3):483-90. PubMed ID: 11810220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSF1 phosphorylation by ERK/GSK3 suppresses RNF126 to sustain IGF-IIR expression for hypertension-induced cardiomyocyte hypertrophy.
    Huang CY; Lee FL; Peng SF; Lin KH; Chen RJ; Ho TJ; Tsai FJ; Padma VV; Kuo WW; Huang CY
    J Cell Physiol; 2018 Feb; 233(2):979-989. PubMed ID: 28383811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy.
    Ueyama T; Kawashima S; Sakoda T; Rikitake Y; Ishida T; Kawai M; Yamashita T; Ishido S; Hotta H; Yokoyama M
    J Mol Cell Cardiol; 2000 Jun; 32(6):947-60. PubMed ID: 10888249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
    Xu Z; Mei F; Liu H; Sun C; Zheng Z
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.
    Adams JW; Sakata Y; Davis MG; Sah VP; Wang Y; Liggett SB; Chien KR; Brown JH; Dorn GW
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10140-5. PubMed ID: 9707614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.